References
-
1) Artesunate inhibits macrophage-like phenotype switching of vascular smooth muscle cells and attenuates vascular inflammatory injury in atherosclerosis via NLRP3.
Year: 2024Journal: Biomed PharmacotherImpactFactor: 7.5DOI: 10.1016/j.biopha.2024.116255PMID: 38325261 -
2) Inhibition of HDAC6 alleviates cancer‑induced bone pain by reducing the activation of NLRP3 inflammasome.
-
3) Blocking CIRP protects against acute pancreatitis by improving mitochondrial function and suppressing pyroptosis in acinar cells.
Year: 2024Journal: Cell Death DiscovImpactFactor: 7DOI: 10.1038/s41420-024-01923-6PMID: 38538578 -
4) Flavonoids from Smilax china L. Rhizome improve chronic pelvic inflammatory disease by promoting macrophage reprogramming via the NLRP3 inflammasome-autophagy pathway.
Year: 2023Journal: J FUNCT FOODSDOI: 10.1016/j.jff.2023.105802 -
5) Pharmacological inhibition of cGAS ameliorates postoperative cognitive dysfunction by suppressing caspase-3/GSDME-dependent pyroptosis.
Year: 2024Journal: Neurochem IntImpactFactor: 4.2DOI: 10.1016/j.neuint.2024.105788PMID: 38843953 -
6) Neuronal-specific TNFAIP1 ablation attenuates postoperative cognitive dysfunction via targeting SNAP25 for K48-linked ubiquitination.
Year: 2023Journal: Cell Commun SignalImpactFactor: 8.4DOI: 10.1186/s12964-023-01390-zPMID: 38102610 -
7) Iron induces B cell pyroptosis through Tom20–Bax–caspase–gasdermin E signaling to promote inflammation post-spinal cord injury.
Year: 2023Journal: J NeuroinflammationImpactFactor: 9.3DOI: 10.1186/s12974-023-02848-0PMID: 37480037 -
8) Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells.
-
9) Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury.
-
10) Inhibition of HDAC6 alleviates cancer‑induced bone pain by reducing the activation of NLRP3 inflammasome.
-
11) Aucubin improves chronic unpredictable mild stress-induced depressive behavior in mice via the GR/NF-κB/NLRP3 axis.
Year: 2023Journal: Int ImmunopharmacolImpactFactor: 5.6DOI: 10.1016/j.intimp.2023.110677PMID: 37523973 -
12) Total flavones of Rhododendron induce the transformation of A1/A2 astrocytes via promoting the release of CBS-produced H2S.
Year: 2023Journal: PHYTOMEDICINEImpactFactor: 7.9DOI: 10.1016/j.phymed.2023.154666PMID: 36701996 -
13) FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer.
Product: FMO2 Antibody (#DF16081)Year: 2023Journal: Front OncolImpactFactor: 4.7DOI: 10.3389/fonc.2023.1144775PMID: 37274237 -
14) LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy.
Product: LRRC3B Antibody (#DF16048)Year: 2023Journal: Front ImmunolImpactFactor: 7.3DOI: 10.3389/fimmu.2023.959868PMID: 36798137 -
15) Directing Differentiation of Pluripotent Stem Cells Toward Retinal Pigment Epithelium Lineage.
Product: CLVS1 Antibody (#DF15830)Year: 2017Journal: Stem Cells Transl MedImpactFactor: 6DOI: 10.5966/sctm.2016-0088